report

OrganiGram Holdings Inc.

chart

I have timestamps + buy fills all in the charts.

$OGI - One of the prettiest charts on the video!

bullish

$OGI $SQUIDGROW.X have y’all heard of CEO of #squidgrow Shibtoshi the billionaire himself great project super bullish the next big thing

$OGI Bullish on all pot stocks 2023 started a position here today🔥📈

business-result

OGI keeps chugging along with upward momentum every quarter.

$OGI Generated a 30% increase in yield per plant in Q1 Fiscal 2023, compared to the same prior year period, as a result of environment improvements.

$OGI OGI has outperformed the industry in Canada and fast approaching cash flow positive in the next 3-4 quarters.

$HEXO In summary: -0.6M EBITDA, a substantial improvement compared to previous quarters.

company

Too good of a company for this stock price.

Strapped with cash, looking for potential buys, BAT investment potential… I have and will continue to like this company

$OGI 
Just became the first profitable Canadian pot company!!

OGI continues to prove itself as the best ran pot company

Very pleased, and very excited about the future!

Organigram grows weed at some of the lowest cost out of other companies while having some of the best quality.

Goldman Sachs Group, Inc.

scam

Grind The Federal Reserve in the garbage disposal.

$GS Investing in this scam stock is like playing a game of chance with your money.

$GS this garbage will underperform all day and close at 318

target

Bunch of rat bastards with pie in the sky price targets and manipulation

$GS scam cunts , they have the worse price targets t manipulation price action.

trading

↳ Why are you paying to be in a Trading Room?

Goldman Sachs is under capitalized and illegally using client money for trading

$GS huge amounts of risky trading which they sucked at last quarter.

$GS 100% spam, lies, et al, not the first time fake dmj has been used, ignore, report this fraudster ron, he&#39;s no guru, my friends, good health and trading to all.

$GS sucks try banking, trading and investing with SoFi come over to $SOFI big banks suck!

$GS shares down -6% for the worst day in 364 trading days (a day shy of the anniversary). Pulling down other banks ($KBE)

analyst

Goldman Sachs missed analysts’ estimates on both the top and bottom lines, with loan loss provisions coming in higher than expected.

$GS traah pos, fk them corrupt scums fake price analyst

but you can’t be down $3.94B QoQ from last year when you have industry peers with less clout $JPM $BAC both pushing out over $2B in profits for the same quarter. Embarrassing.

$GS  atrocious quarter … these pigs overpay themselves richly no matter what their business is doing … no cost control in the compensation and benefits area … embarrassing fail as compared with rival Morgan Stanley

4th straight quarter of declining profits and these guys are heroes???!

$GS amazing this isn&#39;t down 20% on that report

Shares gained +17.9% since the last report https://tinyurl.com/y82f24mq

LOOKS GREAT Technically..Do you know when $GS reports

$SPY I love how $GS expectd the Feds to do what they say 😂 clowns .

$BTC.X $DKNG $GS $QQQ $SPY 
“The world is saying something” that’s a great quote. Cheers.

$QQQ $SPY $DIA $C $GS the banks are all backed with cash, so in my opinion there are no more problems.

$SPY $QQQ $GS well that was easy for bulls today.

$AABB ok new favorite one $AMC $APE.X $SPY $GS  notice the golden shovel

$SPY no rate hike next week $GS now said, very interesting.

bear

.Ready For A Nice Move $25+++ Lots Of Bear Meat Over There!!! DWAC

$GS I dont see too much more downside, bears are getting greedy, in one week we will be back by $360+

🐻❤😈 your 24x7 active short trader care bear specialist for profits  .

$GS tomorrow another bear victory 🐻🐻🐻🐻🐻🐻

Nice fade  on ER 50/50 bet bears got paid this time!

$GS where all my morning bears at 🐻🐻🐻🐻🐻🐻🐻🐻🐻🐻🐻

A nice bear rally next week and overall strength until gdp and end of month QT.

market

$BTC.X here is the 2 quadrillion deravitives market 😂🔥🔥🔥🔥
enjoy the ride fellas $JPM $GS  🖕🏿

$SOFI Fastest growing and best positioned bank in the market especially when compared to the zombie big banks.

$GS  The bullish bias in the options market suggests a positive outlook for the stock We are seeing the $-0.0366561934685327 -11.55 having heavy activity which expire in 65850 days.

$GS 
Reiterates a Market Outperform 
 
🔼 $ 470 PT 
 
At JMP Securities; sees 46% Upside 
 
#GoldmanSachsGr #AnalystRatings

Housing data is up for weeks, job market and economy is stronger then expected, while no available shares to short.

Stay down good for market sentiment $DIA 

Can’t lose

AMD BEFORE IT&#39;S AFTER CLOSE ON TUESDAY THEY CONTINUE TO GROW AS THEY HAVE CONTINUED TO EAT AWAY AT INTEL&#39;S MARKET SHARE.

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

$AVXL since the tutes holding report, it rises, it accelerates!!!

Probably the best written Anavex report on that site.

I&#39;m excited about the new FTD report on the 15th.

$AVXL thank you @MayoMobile for the through, insightful and extremely unique report of AVXL’s CTAD presentation.

SR1 activation covered in has many independent scientific reports, and it is very active in the brain, with positive effects.

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

patient

It can be shown that treatment bringing back independence is less costly than the nursing homes and medical staff.

$AVXL This may show why Anavex is definitely on the right path by using patients personal genetics to determine dosage.

Many claim him to be selfish and unconcerned with others, I see a different Missling, with humility and a deep concern for patients who are suffering.

Half the patients improved over baseline over 1 year.

Blarcamesine’s Phase III clinical trials show similar levels of significant improvement in communication and interaction, as patients had statistically significant improvement in the RSBQ primary endpoint of 72.2% compared to 38.5% on placebo. .

And better still for just those 85% carrying the normal SigmaR1 gene as well as for APOE2 and 3 patients.

new clinical trial results show great promise for treating early Alzheimer’s, giving renewed hope for effective treatments.

Anavex has over 760 patients that have taken it without any significant issues. .

OGI

OrganiGram Holdings Inc.

-26.13%

$0.88 - $0.65

Jan, 12, 2023

Jan, 12, 2023

GS

Goldman Sachs Group, Inc.

-15.26%

$374.40 - $317.28

Feb, 3, 2023

Jan, 17, 2023

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 31, 2023

Jan, 30, 2023

OGI

OrganiGram Holdings Inc.

-26.13%

$0.88 - $0.65

GS

Goldman Sachs Group, Inc.

-15.26%

$374.40 - $317.28

Feb, 3, 2023

Jan, 17, 2023

Jan, 13, 2023

Jan, 10, 2023

Nov, 28, 2022

Nov, 8, 2022

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 31, 2023

Jan, 30, 2023

Jan, 12, 2023

Dec, 7, 2022

Dec, 1, 2022